Gossamer Bio Inc [NASDAQ: GOSS] gained 12.75% or 0.13 points to close at $1.15 with a heavy trading volume of 3078220 shares.
The daily chart for GOSS points out that the company has recorded 45.51% gains over the past six months.
If we look at the average trading volume of 1.39M shares, GOSS reached to a volume of 3078220 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Gossamer Bio Inc [GOSS]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for GOSS shares is $8.67 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on GOSS stock is a recommendation set at 1.25. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Oppenheimer have made an estimate for Gossamer Bio Inc shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on June 25, 2024. While these analysts kept the previous recommendation, Wedbush raised their target price to Outperform. The new note on the price target was released on April 05, 2024, representing the official price target for Gossamer Bio Inc stock. Previously, the target price had yet another drop from $8 to $1.25, while UBS kept a Neutral rating on GOSS stock.
The Average True Range (ATR) for Gossamer Bio Inc is set at 0.09, with the Price to Sales ratio for GOSS stock in the period of the last 12 months amounting to 2.47. The Price to Book ratio for the last quarter was 4.81, with the Price to Cash per share for the same quarter was set at 1.44.
Trading performance analysis for GOSS stock
Gossamer Bio Inc [GOSS] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 25.19. With this latest performance, GOSS shares gained by 12.75% in over the last four-week period, additionally plugging by 45.51% over the last 6 months – not to mention a rise of 38.50% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for GOSS stock in for the last two-week period is set at 68.94, with the RSI for the last a single of trading hit 75.68, and the three-weeks RSI is set at 64.99 for Gossamer Bio Inc [GOSS]. The present Moving Average for the last 50 days of trading for this stock 0.8728, while it was recorded at 1.0315 for the last single week of trading, and 0.8604 for the last 200 days.
Gossamer Bio Inc [GOSS]: A deeper dive into fundamental analysis
Gossamer Bio Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 6.74 and a Current Ratio set at 6.74.
Gossamer Bio Inc [GOSS]: An earnings per share (EPS) analysis
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for GOSS. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Gossamer Bio Inc go to 26.42%.
An analysis of Institutional ownership at Gossamer Bio Inc [GOSS]
There are presently around $78.27%, or 80.94%% of GOSS stock, in the hands of institutional investors. The top three institutional holders of GOSS stocks are: NEA MANAGEMENT COMPANY, LLC with ownership of 18.09 million shares, which is approximately 8.0152%. ARTAL GROUP S.A., holding 13.31 million shares of the stock with an approximate value of $$11.99 million in GOSS stocks shares; and ARTAL GROUP S.A., currently with $$10.59 million in GOSS stock with ownership which is approximately 5.2098%.
